Abstract
The distribution of cochlin and its associated basement membrane proteins (collagen IV, collagen II, laminin-β2, and nidogen-1) were evaluated in the vestibular endorgans of subjects with Meniere’s disease and compared with normal specimens. Cochlin mRNA expression in vestibular endorgans from Meniere’s disease specimens was also investigated. Specimens were obtained from patients who had Meniere’s disease and who were undergoing ablative labyrinthectomy. Control specimens were obtained both from autopsy specimens with documented normal audiovestibular function and from patients undergoing labyrinthectomy for acoustic neuroma excision. In the normal control specimens, cochlin immunoreactivity was found evenly distributed in the stroma of the cristae ampullaris and maculae of the utricle. In Meniere’s specimens, cochlin immunoreactivity was markedly increased; this was associated with an increase in cochlin mRNA expression as shown by real-time reverse transcription with the polymerase chain reaction. Collagen IV and laminin-β2 immunoreactivity was significantly decreased in Meniere’s specimens. Nidogen-1 and collagen II immunoreactivity was unchanged in Meniere’s specimens when compared with normal samples. Cochlin upregulation has been implicated in the hereditary audiovestibulopathy, DFNA9. The increased expression of cochlin and decreased expression of collagen IV and laminin in Meniere’s disease are suggestive that the overexpression of cochlin contributes to the dysfunctional inner ear homeostasis seen in this disease.
Similar content being viewed by others
References
Baloh RW (2001) Prosper Meniere and his disease. Arch Neurol 258:151–156
Bhattacharya SK, Annangudi SP, Salomon RG, Kuchtey RW, Peachey NS, Crabb JW (2005a) Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse. Exp Eye Res 80:741–744
Bhattacharya SK, Rockwood EJ, Smith SD, Bonilha VL, Crabb JS, Kuchtey RW, Robertson GN, Peachey NS, Morton CC, Crabb JW (2005b) Proteomics reveal cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem 280:6080–6084
Chance MR, Chang J, Liu S, Gokulrangan G, Chen DH, Lindsay A, Gen R, Zhen QY, Alagramam K (2010) Proteomics, bioinformatics and targeted gene expression analysis reveals up-regulation of cochlin and identifies other potential biomarkers in the mouse model for deafness in Usher syndrome type 1F. Hum Mol Genet 19:1515–1527
Coelho DH, Lalwani AK (2008) Medical management of Meniere’s disease. Laryngoscope 118:1099–1108
Colombatti A, Bonaldo P (1991) The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77:2305–2315
Committee on Hearing and Equilibrium (1995) Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation. Otolaryngol Head Neck Surg 113:181–185
Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, Siegel M (1998) Ultrastructual, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome. Hear Res 121:84–98
Eikmans M, Baelde JJ, Heer E de, Bruijn JA (2003) Extracellular matrix homeostasis in renal diseases: a genomic approach. J Pathol 200:526–536
Fransen E, Verstreken M, Verhagen WI, Fl W, Huygen PL, D’Haese P, Robertson NG, Morton CC, McGuirt WT, Smith RJ, Declau F, Van de Heyning PH, Van Cam G (1999) High prevalence of symptoms of Meniere’s disease in three families with a mutation in the COCH gene. Hum Mol Genet 8:1425–1429
Goodyear RJ, Richardson GP (2002) Extracellular matrices associated with the apical surfaces of sensory epithelia in the inner ear: molecular and structural diversity. J Neurobiol 53:212–227
Gratton MA, Rao VH, Meehan DT, Askew C, Cosgrove D (2005) Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology. Am J Pathol 166:1465–1474
Hosokawa S, Mizuta K, Nakanishi H, Hashimoto Y, Arai M, Mineta H, Shindo S, Ikezono T (2010) Ultrastructural localization of cochlin in the rat cochlear duct. Audiol Neuro Otol 15:247–253
Ikezono T, Omori A, Ichinose S, Pawankar R, Watanabe A, Yagi T (2001) Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein. Biochem Biophys Acta 1535:258–265
Ikezono T, Shindo S, Ishizaki L, Li L, Tomiyama S, Takumida M, Pawankar R, Watanabe A, Saito A, Yagi T (2005) Expression of cochlin in the vestibular endorgans of rats. ORL J Otolaryngol Relat Spec 67:252–258
Ishiyama A, Mowry SE, Lopez IA, Ishiyama G (2009) Immunohistochemical distribution of basement membrane proteins in the human inner ear from older subjects. Hear Res 254:1–14
Ishiyama G, Lopez IA, Beltran-Parrazal L, Ishiyama A (2010) Immunohistochemical localization and mRNA expression of aquaporins in the macula utriculi of patients with Meniere’s disease and acoustic neuroma. Cell Tissue Res 340:407–419
Jones SM, Robertson NG, Given S, Giersh BS, Liberman MC, Morton CC (2011) Hearing and vestibular deficits in the Coch−/− null mouse model: comparison to the Cochg88E/G88E mouse and to DFNA9 hearing and balance disorder. Hear Res 272:42–48
Kalluri R (2003) Basement membranes: structure, assembly and role in tumor angiogenesis. Nat Rev Cancer 3:422–433
Khetarpal U (2000) DFNA9 is a progressive audiovestibular dysfunction with a microfibrillar deposit in the inner ear. Laryngoscope 110:1379–1384
Khetarpal U, Robertson NG, Yoo TJ, Morton CC (1994) Expression and localization COL2A1 mRNA and type II collagen in human fetal cochlea. Hear Res 79:59–73
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408
McCall A, Ishiyama G, Lopez IA, Bhuta S, Vetter S, Ishiyama A (2009) Histopathological and ultrastructural analysis of vestibular endorgans obtained from patients with Meniere’s disease. BMC Ear Nose Throat Disord 9:4
Meyer zum Gottesberge AM, Felix H (2005) Abnormal basement membrane in the inner ear and the kidney of the Mpv17−/− mouse strain: ultrastructural and immunohistochemical investigations. Histochem Cell Biol 124:507–516
Mizuta K, Ikezono T, Iwasaki S, Arai M, Hashimoto Y, Pawankar R, Watanabe T, Shindo S, Mineta H (2008) Ultrastructural co-localization of cochlin and type II collagen in the rat semicircular canal. Neurosci Lett 434:104–107
Nagy I, Trexler M, Patthy L (2008) The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens. FEBS Lett 582:4003–4007
Robertson NG, Lu L, Heller S, Merchant SN, Eavey RD, McKenna M, Nadol JB Jr, Miyamoto RT, Linthicum FH Jr, Lubianca Nerto JF, Hudspeth AJ, Seidman CE, Morton CC, Seidman JG (1998) Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic sensorineural deafness with vestibular dysfunction. Nat Genet 20:299–303
Robertson NG, Resendes BL, Lin JS, Lee C, Aster JC, Adams JC, Morton CC (2001) Inner ear localization of mRNA and protein products of COCH, mutated in the sensorineural deafness and vestibular disorder, DFNA9. Hum Mol Genet 10:2493–2500
Robertson NG, Cremers C, Huygen PL, Ikezono T, Krastins B, Kremer H, Kuo SF, Liberman MC, Merchant SN, Miller CE, Nadol JB Jr, Sarracino DA, Verhagen WI, Morton CC (2006) Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet 15:1071–1085
Sakaguchi N, Spicer SS, Thomopoulos GN, Schulte BA (1997) Increased laminin deposition in capillaries of the stria vascularis of quiet-aged gerbils. Hear Res 105:44–56
Sanchez E, Lopez-Escamez JA, Lopez-Nevot MA, Lopez-Nevot A, Cortes R, Martin J (2003) Absence of COCH mutations in patients with Meniere disease. Eur J Hum Genet 11:744–748
Sekine K, Ikezono T, Matsumura T, Shindo S, Watanabe A, Li L, Pawankar R, Nishino T, Yagi T (2010) Expression of cochlin mRNA splice variants in the inner ear. Audiol Neurootol 15:88–96
Slepecky NB, Savage JE, Yoo TJ (1992) Localization of type II, IX, and V collagen in the inner ear. Acta Otolaryngol 112:611–617
Soderman AC, Bagger-Sjoback D, Bergenius J, Langius A (2002) Factors influencing quality of life in patients with Meniere’s disease, identified by a multidimensional approach. Otol Neurotol 23:941–948
Tryggvason K, Wartiovaaara J (2001) Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10:534–549
Tsuprun V, Santi P (1999) Ultrastructure and immunohistochemical identification of the extracellular matrix of the chinchilla cochlea. Hear Res 129:35–49
Usami S, Takahashi K, Yuge I, Ohtsuka A, Namba A, Abe S, Fransen E, Patthy L, Otting G, Van Camp G (2003) Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleovestibular dysfunction, but not of Meniere’s disease. Eur J Hum Genet 11:744–748
Zehnder A, Adams J, Santi PA, Kristiansen AG, Wacharasindhu C, Mann S, Kalluri R, Gregory MC, Kashtan CE, Merchant SN (2005) Distribution of type IV collagen in the cochlea in Alport’s syndrome. Arch Otolaryngol Head Neck Surg 131:1007–1113
Author information
Authors and Affiliations
Corresponding author
Additional information
Meniere’s disease also known as Menière's or Ménière’s disease.
This work was supported by National Institutes of Health grant 5U24 DC 008635 (NIDCD).
Rights and permissions
About this article
Cite this article
Calzada, A.P., Lopez, I.A., Beltran Parrazal, L. et al. Cochlin expression in vestibular endorgans obtained from patients with Meniere’s disease. Cell Tissue Res 350, 373–384 (2012). https://doi.org/10.1007/s00441-012-1481-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-012-1481-x